Zachary Moore, MD
Sports Medicine · Guntersville, ALNPI 1619330719
Payments from drug & device makers
What this record shows
This record is dominated by grants: $25,984 of the $32,512 with a category attached, or 79.9%. Arthrex accounts for 64.9% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2021 at $27,018 and has fallen 95.0% since, to $1,344 in 2025.
Across 60 payments — averaging $541.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$21K
- Smith+Nephew$4K
- Medical Device Business Services, Inc.$3K
- DJO, LLC$3K
- Zimmer Biomet$379
- Johnson & Johnson$289
- plus $1K from 12 others
What the payments were for
- Grants$25,98480%
- Travel & lodging$6082%
- Food & beverage$2,2537%
- Education$3,66711%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 17 | $21,110 |
| Smith+Nephew | 2 | $3,667 |
| Medical Device Business Services, Inc. | 1 | $3,484 |
| DJO, LLC | 5 | $2,519 |
| Zimmer Biomet | 6 | $379 |
| Johnson & Johnson | 5 | $289 |
| Skeletal Dynamics Inc | 2 | $188 |
| Bioventus LLC | 4 | $167 |
| Stryker | 1 | $165 |
| Prime Surgical, LLC | 5 | $133 |
| Acell, Inc. | 1 | $122 |
| Kerecis Limited | 4 | $98 |
| Alcresta Therapeutics, Inc. | 1 | $51 |
| Trimed, Inc. | 1 | $45 |
| Pacira Therapeutics, Inc. | 2 | $41 |
| Illuminoss Medical, Inc. | 1 | $22 |
| Amgen | 1 | $17 |
| Medtronic | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$32,512 in reported general payments places this provider in the 85th percentile of 108 sports medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 93 | $709 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 77 | $478 |
| Methylprednisolone | 36 | $240 |
| Ondansetron Hcl | 60 | $222 |
| Meloxicam | 108 | $214 |
| Cyclobenzaprine Hcl | 63 | $177 |
| Doxycycline Hyclate | 24 | $132 |
| Tramadol Hcl | 44 | $106 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $62 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Guntersville
- Matthew SmithGuntersville$73K
- Edward CainBirmingham$12.7M
- Daniel MatthewsDaphne$190K
- Mark RogersBirmingham$94K
- Amit MomayaBirmingham$77K
- Christoper GarrettBirmingham$58K
- Jonathan IsbellHoover$55K
- James McMurtrieHuntsville$54K
- Reaves CrabtreeBirmingham$47K
- David AdkisonBirmingham$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.